跳至主要内容
临床试验/IRCT2017071322991N8
IRCT2017071322991N8已完成3 期

Effectiveness of Metformin in the control of weight gain related to sodium valproate administration in adults

Vice chancellor for research of Babol University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • age 18 to 65 years; under medication with sodium valproate for at least one month; self-reported weight gain more than three kilogram after sodium valproate administration; filling and assignment the informed consent form
  • Exclusion criteria: diabetes in the patient; endocrine disorder in which the patient is treated with steroids; administration other psychotropic drugs except sodium valproate; suspect to polycystic ovarian disease in the patient; mental retardation or other severe physical or mental disorders which inhibit the cooperation of the patient in the research; pregnancy and breast-feeding; impairment of renal or hepatic function (creatinine or liver enzymes more than 150 percent higher than normal value); alcohol, narcotic and psychotropic drugs consumption

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Babol University of Medical Sciences

相似试验